NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-078-2006-0-GB-09 CELLULAR RECEPTOR FOR ANTIPROLIFERATIVE FACTOR GB EP 07813497.0 Abandoned
NCI E-078-2006-0-EP-05 CELLULAR RECEPTOR FOR ANTIPROLIFERATIVE FACTOR EP National Stage 07813497.0 Abandoned
NCI E-078-2006-0-FR-08 CELLULAR RECEPTOR FOR ANTIPROLIFERATIVE FACTOR FR EP 07813497.0 Abandoned
NCI E-078-2006-0-DE-07 CELLULAR RECEPTOR FOR ANTIPROLIFERATIVE FACTOR DE EP 07813497.0 Abandoned
NCI E-317-2002-0-US-07 Molecular Characteristics of Non-Small Cell Lung Cancer US CON 11/829,483 7709202 Expired PDF
NCI E-078-2006-0-PCT-02 CELLULAR RECEPTOR FOR ANTIPROLIFERATIVE FACTOR PCT PCT PCT/US2007/074643 Expired
NCI E-078-2006-0-CA-04 CELLULAR RECEPTOR FOR ANTIPROLIFERATIVE FACTOR CA National Stage 2658952 Abandoned
NCI E-078-2006-0-AU-03 CELLULAR RECEPTOR FOR ANTIPROLIFERATIVE FACTOR AU National Stage 2007278864 Abandoned
NIBIB E-279-2006-0-US-01 Maxwellian View Photo-simulation/illumination Of Your Discovery For Use With Commercial Fundus Camera US 60/935,107 Abandoned
NCI E-108-2004-1-AU-06 METHODS FOR IDENTIFYING, DIAGNOSING, AND PREDICTING SURVIVAL OF LYMPHOMAS AU National Stage 2007277142 Issued
NHGRI E-055-2005-2-US-02 Farnesyl Transferase Inhibitors For Treatment of Laminopathies, Cellular Aging, And Artherosclerosis US ORD 11/828,117 7838531 Issued PDF
NIDA E-087-2002-0-US-09 Methods For Treating Cardiac Arrhythmia US CON 11/878,611 7700600 Expired PDF
NCI E-108-2004-1-PCT-02 METHODS FOR IDENTIFYING, DIAGNOSING, AND PREDICTING SURVIVAL OF LYMPHOMAS PCT PCT PCT/US2007/016843 Expired
NCI E-108-2004-1-EP-03 METHODS FOR IDENTIFYING, DIAGNOSING, AND PREDICTING SURVIVAL OF LYMPHOMAS EP National Stage 07810823.0 Abandoned
NCI E-108-2004-1-EP-07 METHODS FOR IDENTIFYING, DIAGNOSING, AND PREDICTING SURVIVAL OF LYMPHOMAS EP DIV 10014565.5 Abandoned
NCI E-108-2004-1-CA-05 METHODS FOR IDENTIFYING, DIAGNOSING, AND PREDICTING SURVIVAL OF LYMPHOMAS CA National Stage 2659194 Abandoned
NCI E-292-2001-1-US-03 Use Of Mx GTPase In The Prognosis And Treatment Of Cancer US DIV 11/781,399 Abandoned
NIAID E-109-2007-0-US-01 Detection of Infectious Prion Protein by Seeded Conversion of Recombinant Prion Protein US 60/961,364 Abandoned
NCI E-061-2007-0-US-01 GENE EXPRESSION PROFILE FOR PREDICTING OVARIAN CANCER PATIENT SURVIVAL US 60/951,073 Abandoned
NCI E-282-2000-0-US-08 Analogs of Thalidomide as Potential Angiogenesis Inhibitors US CON 11/880,404 8716315 Abandoned PDF
NICHD E-096-2004-1-US-01 Multi-purpose Temperature-controlled, Flow-through Miorcel For Anayical Transmission Infared Spectoscopy And Microsopy Of Liquid And Sold Samples US CIP 11/826,806 7894055 Abandoned PDF
NICHD E-183-2005-0-PCT-02 Methods For Conjugation Of Oligosaccharides Or Polysaccharides To Protein Carriers Through Oxime Linkages Via 3-Deoxy-D-Manno-Octulsonic Acid PCT PCT PCT/US2007/016373 Expired
NHLBI E-208-2007-0-US-01 IMIDAZOLIDINONE COMPOUNDS, METHODS TO INHIBIT DEUBIQUITINATION AND METHODS OF TREATMENT US 60/961,202 Abandoned
NCI E-200-1998-0-AU-10 Fitness Assay and Associated Methods AU DIV 2007203321 Expired
NCI E-194-2007-0-US-01 Trifunctional Imaging Agent for Monoclonal Antibody Tumor-Targeted Imaging US 60/929,913 Abandoned
NIDDK E-218-2007-1-US-01 A2 Adenosine Receptor Agonists US 60/950,250 Abandoned
NCI E-263-2006-1-IT-07 METHODS OF DETERMINING THE PROGNOSIS OF AN ADENOCARCINOMA IT EP 07799622.1 Issued
NCI E-263-2006-1-FR-05 METHODS OF DETERMINING THE PROGNOSIS OF AN ADENOCARCINOMA FR EP 07799622.1 Issued
NCI E-263-2006-1-DE-04 METHODS OF DETERMINING THE PROGNOSIS OF AN ADENOCARCINOMA DE EP 07799622.1 Abandoned
NCI E-263-2006-1-EP-03 METHODS OF DETERMINING THE PROGNOSIS OF AN ADENOCARCINOMA EP National Stage 07799622.1 Issued
NCI E-263-2006-1-GB-06 METHODS OF DETERMINING THE PROGNOSIS OF AN ADENOCARCINOMA GB EP 07799622.1 Issued
NCI E-263-2006-1-PCT-01 METHODS OF DETERMINING THE PROGNOSIS OF AN ADENOCARCINOMA PCT PCT COMB PCT/US2007/073637 Expired
NINDS E-143-2002-1-US-09 METHOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS US DIV 11/827,876 8454965 Abandoned PDF
NCI E-237-2006-0-ES-06 ABCB1 GENOTYPING TO PREDICT MICROTUBULE-STABILIZING-AGENT-INDUCED TOXICITY ES EP 07799583.5 Issued
NCI E-237-2006-0-GB-08 ABCB1 GENOTYPING TO PREDICT MICROTUBULE-STABILIZING-AGENT-INDUCED TOXICITY GB EP 07799583.5 Abandoned
NCI E-237-2006-0-EP-03 ABCB1 GENOTYPING TO PREDICT MICROTUBULE-STABILIZING-AGENT-INDUCED TOXICITY EP National Stage 07799583.5 Issued
NCI E-237-2006-0-FR-07 ABCB1 GENOTYPING TO PREDICT MICROTUBULE-STABILIZING-AGENT-INDUCED TOXICITY FR EP 07799583.5 Issued
NCI E-237-2006-0-DE-05 ABCB1 GENOTYPING TO PREDICT MICROTUBULE-STABILIZING-AGENT-INDUCED TOXICITY DE EP 07799583.5 Issued
NCI E-237-2006-0-IT-09 ABCB1 GENOTYPING TO PREDICT MICROTUBULE-STABILIZING-AGENT-INDUCED TOXICITY IT EP 07799583.5 Issued
NCI E-237-2006-0-PCT-02 ABCB1 GENOTYPING TO PREDICT MICROTUBULE-STABILIZING-AGENT-INDUCED TOXICITY PCT PCT PCT/US2007/073497 Expired
NIAID E-144-2004-0-US-05 Monoclonal Antibodies That Bind or Neutralize Hepatitis B Virus US National Stage 11/795,255 Abandoned
NCI E-290-2006-2-CN-16 MICRO-RNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF COLON CANCER-RELATED DISEASES CN National Stage 200780033066.9 Abandoned
NCI E-290-2006-2-IT-88 MIR-21 for diagnosing poor survival prognosis colon adenocarcinoma. IT EP 11196265.0 Abandoned
NCI E-290-2006-2-DE-86 MIR-21 for diagnosing poor survival prognosis colon adenocarcinoma. DE EP 11196265.0 Abandoned
NCI E-290-2006-2-EP-25 MIR-21 for diagnosing poor survival prognosis colon adenocarcinoma. EP DIV 11196265.0 Abandoned
NCI E-290-2006-2-GB-87 MIR-21 for diagnosing poor survival prognosis colon adenocarcinoma. GB EP 11196265.0 Abandoned
NCI E-290-2006-2-CH-48 Micro-RNA-based methods and compositions for the diagnosis and treatment of colon related diseases CH EP 11196250.2 Abandoned
NCI E-290-2006-2-GB-52 Micro-RNA-based methods and compositions for the diagnosis and treatment of colon related diseases GB EP 11196250.2 Abandoned
NCI E-290-2006-2-ES-50 Micro-RNA-based methods and compositions for the diagnosis and treatment of colon related diseases ES EP 11196250.2 Abandoned
NCI E-290-2006-2-EP-18 Micro-RNA-based methods and compositions for the diagnosis and treatment of colon related diseases EP DIV 11196250.2 Abandoned